Anti-Vascular Endothelial Growth Factor/Programmed Cell Death Protein 1 Bispecific Antibodies: Using Nunchucks to Fight an Old Adversary

J Thorac Oncol. 2024 Mar;19(3):366-369. doi: 10.1016/j.jtho.2023.12.001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Bispecific* / metabolism
  • Antibodies, Bispecific* / pharmacology
  • Antibodies, Bispecific* / therapeutic use
  • Endothelial Growth Factors
  • Humans
  • Lung Neoplasms*
  • Programmed Cell Death 1 Receptor
  • Vascular Endothelial Growth Factor A

Substances

  • Antibodies, Bispecific
  • Endothelial Growth Factors
  • Programmed Cell Death 1 Receptor
  • Vascular Endothelial Growth Factor A